{"id":15961,"date":"2022-03-03T12:57:36","date_gmt":"2022-03-03T11:57:36","guid":{"rendered":"https:\/\/convergences.online\/hemato\/?p=15961"},"modified":"2022-03-03T12:57:36","modified_gmt":"2022-03-03T11:57:36","slug":"carvykti-ciltacabtagene-autoleucel-cellules-car-t-ciblant-bcma-un-medicament-developpe-par-johnsonjohnson-contre-le-myelome-obtient-lapprobation-de-la-fda-pour-une-mise-sur-le-marche","status":"publish","type":"post","link":"https:\/\/www.hematostat.net\/en\/carvykti-ciltacabtagene-autoleucel-cellules-car-t-ciblant-bcma-un-medicament-developpe-par-johnsonjohnson-contre-le-myelome-obtient-lapprobation-de-la-fda-pour-une-mise-sur-le-marche\/","title":{"rendered":"Carvykti\u00ae(ciltacabtagene autoleucel, cellules CAR T ciblant BCMA), un m\u00e9dicament d\u00e9velopp\u00e9 par Johnson&Johnson contre le my\u00e9lome, obtient l’approbation de la FDA pour une mise sur le march\u00e9."},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":17,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"categories":[21],"tags":[],"ppma_author":[457],"class_list":["post-15961","post","type-post","status-publish","format-standard","hentry","category-communique-de-presse","author-pascale-raoul"],"aioseo_notices":[],"authors":[{"term_id":457,"user_id":17,"is_guest":0,"slug":"pascale-raoul","display_name":"Pascale Raoul","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","first_name":"","last_name":"","user_url":"","description":""}],"_links":{"self":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/posts\/15961","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/users\/17"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/comments?post=15961"}],"version-history":[{"count":0,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/posts\/15961\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/media?parent=15961"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/categories?post=15961"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/tags?post=15961"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/ppma_author?post=15961"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}